{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T21:39:57Z","timestamp":1740173997281,"version":"3.37.3"},"reference-count":61,"publisher":"National Institute for Health and Care Research","issue":"60","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.nationalarchives.gov.uk\/doc\/non-commercial-government-licence\/non-commercial-government-licence.htm"}],"funder":[{"DOI":"10.13039\/501100000664","name":"Health Technology Assessment programme","doi-asserted-by":"publisher","award":["12\/201\/02"],"award-info":[{"award-number":["12\/201\/02"]}],"id":[{"id":"10.13039\/501100000664","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Health Technol Assess"],"abstract":"Background<\/jats:title>Biological treatments such as adalimumab (Humira\u00ae<\/jats:sup>; AbbVie Ltd, Maidenhead, UK) are antibodies targeting tumour necrosis factor alpha, released from ruptured intervertebral discs, which might be useful in sciatica. Recent systematic reviews concluded that they might be effective, but that a definitive randomised controlled trial was needed. Usual care in the NHS typically includes a physiotherapy intervention.<\/jats:p><\/jats:sec>Objectives<\/jats:title>To test whether or not injections of adalimumab plus physiotherapy are more clinically effective and cost-effective than injections of saline plus physiotherapy for patients with sciatica.<\/jats:p><\/jats:sec>Design<\/jats:title>Pragmatic, parallel-group, randomised controlled trial with blinded participants and clinicians, and an outcome assessment and statistical analysis with concurrent economic evaluation and internal pilot.<\/jats:p><\/jats:sec>Setting<\/jats:title>Participants were referred from primary care and musculoskeletal services to outpatient physiotherapy clinics.<\/jats:p><\/jats:sec>Participants<\/jats:title>Adults with persistent symptoms of sciatica of 1\u20136 months\u2019 duration and with moderate to high levels of disability. Eligibility was assessed by research physiotherapists according to clinical criteria for diagnosing sciatica.<\/jats:p><\/jats:sec>Interventions<\/jats:title>After a second eligibility check, trial participants were randomised to receive two doses of adalimumab (80\u2009mg and then 40\u2009mg 2 weeks later) or saline injections. Both groups were referred for a course of physiotherapy.<\/jats:p><\/jats:sec>Main outcome measures<\/jats:title>Outcomes were measured at the start, and after 6 weeks\u2019 and 6 months\u2019 follow-up. The main outcome measure was the Oswestry Disability Index (ODI). Other outcomes: leg pain version of the Roland\u2013Morris Disability Questionnaire, Sciatica Bothersomeness Index, EuroQol-5 Dimensions, 5-level version, Hospital Anxiety and Depression Scale, resource use, risk of persistent disabling pain, pain trajectory based on a single question, Pain Self-Efficacy Questionnaire, Tampa Scale of Kinesiophobia and adverse effects.<\/jats:p><\/jats:sec>Sample size<\/jats:title>To detect an effect size of 0.4 with 90% power, a 5% significance level for a two-tailedt<\/jats:italic>-test and 80% retention rate, 332 participants would have needed to be recruited.<\/jats:p><\/jats:sec>Analysis plan<\/jats:title>The primary effectiveness analysis would have been linear mixed models for repeated measures to measure the effects of time and group allocation. An internal pilot study would have involved the first 50 participants recruited across all centres. The primary economic analysis would have been a cost\u2013utility analysis.<\/jats:p><\/jats:sec>Results<\/jats:title>The internal pilot study was discontinued as a result of low recruitment after eight participants were recruited from two out of six sites. One site withdrew from the study before recruitment started, one site did not complete contract negotiations and two sites signed contracts shortly before trial closure. In the two sites that did recruit participants, recruitment was slow. This was partly because of operational issues, but also because of a low rate of uptake from potential participants.<\/jats:p><\/jats:sec>Limitations<\/jats:title>Although large numbers of invitations were sent to potential participants, identified by retrospective searches of general practitioner (GP) records, there was a low rate of uptake. Two sites planned to recruit participants during GP consultations but opened too late to recruit any participants.<\/jats:p><\/jats:sec>Conclusion<\/jats:title>The main failure was attributable to problems with contracts. Because of this we were not able to complete the internal pilot or to test all of the different methods for primary care recruitment we had planned. A trial of biological therapy in patients with sciatica still needs to be done, but would require a clearer contracting process, qualitative research to ensure that patients would be willing to participate, and simpler recruitment methods.<\/jats:p><\/jats:sec>Trial registration<\/jats:title>Current Controlled Trials ISRCTN14569274.<\/jats:p><\/jats:sec>Funding<\/jats:title>This project was funded by the National Institute for Health Research (NIHR) Health Technology Assessment programme and will be published in full inHealth Technology Assessment<\/jats:italic>; Vol. 21, No. 60. See the NIHR Journals Library website for further project information.<\/jats:p><\/jats:sec>","DOI":"10.3310\/hta21600","type":"journal-article","created":{"date-parts":[[2017,10,25]],"date-time":"2017-10-25T10:33:22Z","timestamp":1508927602000},"page":"1-180","update-policy":"https:\/\/doi.org\/10.3310\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":1,"title":["Subcutaneous Injection of Adalimumab Trial compared with Control (SCIATiC): a randomised controlled trial of adalimumab injection compared with placebo for patients receiving physiotherapy treatment for sciatica"],"prefix":"10.3310","volume":"21","clinical-trial-number":[{"clinical-trial-number":"isrctn14569274","registry":"10.18810\/isrctn","type":"results"}],"author":[{"given":"Nefyn H","family":"Williams","sequence":"first","affiliation":[{"name":"School of Healthcare Sciences, Bangor University, Bangor, UK"},{"name":"Betsi Cadwaladr University Health Board, Bangor, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alison","family":"Jenkins","sequence":"additional","affiliation":[{"name":"School of Healthcare Sciences, Bangor University, Bangor, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nia","family":"Goulden","sequence":"additional","affiliation":[{"name":"School of Healthcare Sciences, Bangor University, Bangor, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zoe","family":"Hoare","sequence":"additional","affiliation":[{"name":"School of Healthcare Sciences, Bangor University, Bangor, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dyfrig A","family":"Hughes","sequence":"additional","affiliation":[{"name":"School of Healthcare Sciences, Bangor University, Bangor, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eifiona","family":"Wood","sequence":"additional","affiliation":[{"name":"School of Healthcare Sciences, Bangor University, Bangor, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nadine E","family":"Foster","sequence":"additional","affiliation":[{"name":"Research Institute of Primary Care and Health Sciences, Keele University, Keele, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David A","family":"Walsh","sequence":"additional","affiliation":[{"name":"Arthritis Research UK Pain Centre Division of Rheumatology, Orthopaedics and Dermatology, University of Nottingham, Nottingham, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dawn","family":"Carnes","sequence":"additional","affiliation":[{"name":"Centre for Primary Care and Public Health, Bart\u2019s and the London School of Medicine and Dentistry, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valerie","family":"Sparkes","sequence":"additional","affiliation":[{"name":"School of Healthcare Sciences, Cardiff University, Cardiff, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elaine M","family":"Hay","sequence":"additional","affiliation":[{"name":"Research Institute of Primary Care and Health Sciences, Keele University, Keele, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Isaacs","sequence":"additional","affiliation":[{"name":"National Institute for Health Research Newcastle Biomedical Research Centre, Newcastle University, Newcastle upon Tyne, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kika","family":"Konstantinou","sequence":"additional","affiliation":[{"name":"Research Institute of Primary Care and Health Sciences, Keele University, Keele, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dylan","family":"Morrissey","sequence":"additional","affiliation":[{"name":"Centre for Sports and Exercise Medicine, William Harvey Research Institute, Bart\u2019s and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaro","family":"Karppinen","sequence":"additional","affiliation":[{"name":"Medical Research Centre Oulu, University of Oulu, Oulu, Finland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephane","family":"Genevay","sequence":"additional","affiliation":[{"name":"Rheumatology Department, Geneva University Hospitals, Geneva, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clare","family":"Wilkinson","sequence":"additional","affiliation":[{"name":"School of Healthcare Sciences, Bangor University, Bangor, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"6221","published-online":{"date-parts":[[2017,10]]},"reference":[{"key":"key20171025112535478_ref1-bib1","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1001\/jama.1992.03490060092030","article-title":"What can the history and physical examination tell us about low back pain?","volume":"268","author":"Deyo","year":"1992","journal-title":"JAMA"},{"key":"key20171025112535478_ref1-bib2","doi-asserted-by":"crossref","first-page":"2464","DOI":"10.1097\/BRS.0b013e318183a4a2","article-title":"Sciatica: review of epidemiological studies and prevalence estimates","volume":"33","author":"Konstantinou","year":"2008","journal-title":"Spine"},{"key":"key20171025112535478_ref1-bib3","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1097\/00007632-199309010-00006","article-title":"The natural course of acute sciatica with nerve root symptoms in a double-blind placebo-controlled trial evaluating the effect of piroxicam","volume":"18","author":"Weber","year":"1993","journal-title":"Spine"},{"key":"key20171025112535478_ref1-bib4","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1097\/00007632-199210000-00013","article-title":"The natural history of sciatica associated with disc pathology. A prospective study with clinical and independent radiologic follow-up","volume":"17","author":"Bush","year":"1992","journal-title":"Spine"},{"key":"key20171025112535478_ref1-bib5","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/S0895-4356(03)00257-9","article-title":"Natural history and prognostic indicators of sciatica","volume":"57","author":"Tubach","year":"2004","journal-title":"J Clin Epidemiol"},{"key":"key20171025112535478_ref1-bib6","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1136\/bmj.39223.428495.BE","article-title":"Diagnosis and treatment of sciatica","volume":"334","author":"Koes","year":"2007","journal-title":"BMJ"},{"key":"key20171025112535478_ref1-bib7","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1007\/s00586-007-0367-1","article-title":"Effectiveness of conservative treatments for the lumbosacral radicular syndrome: a systematic review","volume":"16","author":"Luijsterburg","year":"2007","journal-title":"Eur Spine J"},{"volume-title":"Hospital Episode Statistics, Admitted Patient Care England, 2013\u201314: Procedures and Interventions.","year":"2015","author":"Health and Social Care Information Centre","key":"key20171025112535478_ref1-bib8"},{"key":"key20171025112535478_ref1-bib9","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/0304-3959(94)00272-G","article-title":"A cost-of-illness study of back pain in the Netherlands","volume":"62","author":"van Tulder","year":"1995","journal-title":"Pain"},{"key":"key20171025112535478_ref1-bib10","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1056\/NEJM193408022110506","article-title":"Rupture of the intervertebral disc with involvement of the spinal canal","volume":"211","author":"Mixer","year":"1934","journal-title":"N Engl J Med"},{"key":"key20171025112535478_ref1-bib11","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S0049-0172(98)80029-2","article-title":"The role of inflammation in disk herniation-associated radiculopathy","volume":"28","author":"Goupille","year":"1998","journal-title":"Semin Arthritis Rheum"},{"key":"key20171025112535478_ref1-bib12","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1097\/00007632-198401000-00004","article-title":"Pathoanatomy and pathophysiology of nerve root compression","volume":"9","author":"Rydevik","year":"1984","journal-title":"Spine"},{"key":"key20171025112535478_ref1-bib13","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1097\/00002508-199909000-00008","article-title":"Relation between pain location and disc pathology: a study of pain drawings and CT\/discography","volume":"15","author":"Ohnmeiss","year":"1999","journal-title":"Clin J Pain"},{"key":"key20171025112535478_ref1-bib14","doi-asserted-by":"crossref","first-page":"E149","DOI":"10.1097\/00007632-200104010-00015","article-title":"Severity of symptoms and signs in relation to magnetic resonance imaging findings among sciatic patients","volume":"26","author":"Karppinen","year":"2001","journal-title":"Spine"},{"key":"key20171025112535478_ref1-bib15","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1097\/00002517-200012000-00001","article-title":"Conservative treatment of sciatica: a systematic review","volume":"13","author":"Vroomen","year":"2000","journal-title":"J Spinal Disord"},{"key":"key20171025112535478_ref1-bib16","doi-asserted-by":"crossref","first-page":"319","DOI":"10.36076\/ppj.2003\/6\/319","article-title":"Epidural steroids in the management of chronic spinal pain and radiculopathy","volume":"6","author":"Boswell","year":"2003","journal-title":"Pain Physician"},{"key":"key20171025112535478_ref1-bib17","doi-asserted-by":"crossref","first-page":"185","DOI":"10.36076\/ppj.2007\/10\/185","article-title":"Epidural steroids in the management of chronic spinal pain: a systematic review","volume":"10","author":"Abdi","year":"2007","journal-title":"Pain Physician"},{"volume-title":"04\/04\/2012 Humira \u2013 EMEAHC00481-II0082. Product Information","author":"European Medicines Agency","key":"key20171025112535478_ref1-bib18"},{"key":"key20171025112535478_ref1-bib19","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1093\/rheumatology\/keh013","article-title":"TNF-alpha blockade for herniated intervertebral disc-induced sciatica: a way forward at last?","volume":"43","author":"Cooper","year":"2004","journal-title":"Rheumatology"},{"issue":"39","key":"key20171025112535478_ref1-bib20","doi-asserted-by":"crossref","DOI":"10.3310\/hta15390","article-title":"The clinical effectiveness and cost-effectiveness of management strategies for sciatica: systematic review and economic model","volume":"15","author":"Lewis","year":"2011","journal-title":"Health Technol Assess"},{"key":"key20171025112535478_ref1-bib21","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1007\/s00586-013-2739-z","article-title":"A systematic review and meta-analysis of biological treatments targeting tumour necrosis factor alpha for sciatica","volume":"22","author":"Williams","year":"2013","journal-title":"Eur Spine J"},{"key":"key20171025112535478_ref1-bib22","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1097\/ALN.0b013e3181a05aa0","article-title":"Randomized, double-blind, placebo controlled, dose-response and preclinical safety study of transforaminal epidural etanercept for the treatment of sciatica","volume":"110","author":"Cohen","year":"2009","journal-title":"Anesthesiology"},{"key":"key20171025112535478_ref1-bib23","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1002\/art.27499","article-title":"Adalimumab in severe and acute sciatica: a multicenter, randomized, double-blind, placebo-controlled trial","volume":"62","author":"Genevay","year":"2010","journal-title":"Arthrit Rheum"},{"key":"key20171025112535478_ref1-bib24","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1097\/BSD.0b013e31819afdc4","article-title":"Tumour necrosis factor \u03b1-blocking agent (etanercept); a triple blind randomized controlled trial of its use in treatment of sciatica","volume":"23","author":"Okoro","year":"2010","journal-title":"J Spinal Disord Tech"},{"key":"key20171025112535478_ref1-bib25","doi-asserted-by":"crossref","first-page":"9","DOI":"10.2174\/1876532700901010009","article-title":"The efficacy of infliximab in sciatica induced by disc herniations located at L3\/4 or L4\/5: a small-scale randomized controlled trial","volume":"1","author":"Karppinen","year":"2009","journal-title":"Open Spine J"},{"key":"key20171025112535478_ref1-bib26","doi-asserted-by":"crossref","first-page":"2759","DOI":"10.1097\/01.brs.0000245873.23876.1e","article-title":"The treatment of disc-herniation-induced sciatica with infliximab: one-year follow-up results of FIRST II, a randomized controlled trial","volume":"31","author":"Korhonen","year":"2006","journal-title":"Spine"},{"key":"key20171025112535478_ref1-bib27","doi-asserted-by":"crossref","first-page":"551","DOI":"10.7326\/0003-4819-156-8-201204170-00397","article-title":"Epidural steroids, etanercept, or saline in subacute sciatica: a multicenter, randomized trial","volume":"156","author":"Cohen","year":"2012","journal-title":"Ann Intern Med"},{"key":"key20171025112535478_ref1-bib28","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1097\/01.brs.0000141179.58778.6c","article-title":"Efficacy of infliximab for disc herniation-induced sciatica: one-year follow-up","volume":"29","author":"Korhonen","year":"2004","journal-title":"Spine"},{"key":"key20171025112535478_ref1-bib29","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1136\/ard.2003.016451","article-title":"Efficacy of etanercept in the treatment of acute, severe sciatica: a pilot study","volume":"63","author":"Genevay","year":"2004","journal-title":"Ann Rheum Dis"},{"key":"key20171025112535478_ref1-bib30","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1097\/BRS.0b013e3181076514","article-title":"Efficacy of epidural perineural injections with autologous conditioned serum for lumbar radicular compression: an investigator-initiated, prospective, double-blind, reference-controlled study","volume":"32","author":"Becker","year":"2007","journal-title":"Spine"},{"key":"key20171025112535478_ref1-bib31","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1016\/j.pain.2014.04.008","article-title":"Cost-effectiveness of different strategies to manage patients with sciatica","volume":"155","author":"Fitzsimmons","year":"2014","journal-title":"Pain"},{"key":"key20171025112535478_ref1-bib32","volume-title":"British National Formulary","author":"Joint Formulary Committee","year":"2012","edition":"63rd edn."},{"key":"key20171025112535478_ref1-bib33","first-page":"271","article-title":"The Oswestry low back pain disability questionnaire","volume":"66","author":"Fairbank","year":"1980","journal-title":"Physiotherapy"},{"key":"key20171025112535478_ref1-bib34","first-page":"199","article-title":"EuroQol: a new facility for the measurement of health related quality of life","volume":"16","author":"EuroQol Group","year":"1999","journal-title":"Health Policy"},{"volume-title":"A General Practice Approach to Management of Widespread Musculoskeletal Pain and Fibromyalgia","year":"2003","author":"Arthritis Research UK","key":"key20171025112535478_ref1-bib35"},{"key":"key20171025112535478_ref1-bib36","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1002\/sim.4175","article-title":"Generalized method for adaptive randomization in clinical trials","volume":"30","author":"Russell","year":"2011","journal-title":"Stat Med"},{"key":"key20171025112535478_ref1-bib37","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3233\/BMR-2005-183-401","article-title":"Lumbar stabilizing exercises improve activities of daily living in patients with lumbar disc herniation","volume":"18","author":"Bakhtiary","year":"2005","journal-title":"BMR"},{"key":"key20171025112535478_ref1-bib38","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1097\/BRS.0b013e31821ace7f","article-title":"The efficacy of systematic active conservative treatment for patients with severe sciatica: a single-blinded randomized clinical controlled trial","volume":"37","author":"Albert","year":"2012","journal-title":"Spine"},{"key":"key20171025112535478_ref1-bib39","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1471-2474-13-4","article-title":"Clinical course, characteristics and prognostic indicators in patients presenting with back and leg pain in primary care. The ATLAS study protocol","volume":"13","author":"Konstantinou","year":"2012","journal-title":"BMC Musculoskel Disord"},{"key":"key20171025112535478_ref1-bib40","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1002\/sim.4780090113","article-title":"The role of internal pilot studies in increasing the efficiency of clinical trials","volume":"9","author":"Wittes","year":"1990","journal-title":"Stat Med"},{"key":"key20171025112535478_ref1-bib41","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/00007632-198303000-00004","article-title":"A study of the natural history of back pain. Part I: development of a reliable and sensitive measure of disability in low-back pain","volume":"8","author":"Roland","year":"1983","journal-title":"Spine"},{"key":"key20171025112535478_ref1-bib42","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1007\/s00701-010-0679-5","article-title":"A modified Roland\u2013Morris disability scale for the assessment of sciatica","volume":"152","author":"Kim","year":"2010","journal-title":"Acta Neurochir"},{"key":"key20171025112535478_ref1-bib43","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s00586-009-1042-5","article-title":"The bothersomeness of sciatica: patients\u2019 self-report of paresthesia, weakness and leg pain","volume":"19","author":"Gr\u00f8vle","year":"2010","journal-title":"Eur Spine J"},{"key":"key20171025112535478_ref1-bib44","doi-asserted-by":"crossref","first-page":"E455","DOI":"10.1097\/01.brs.0000174274.38485.ee","article-title":"Interrater reliability of scoring of pain drawings in a self-report health survey","volume":"30","author":"Lacey","year":"2005","journal-title":"Spine"},{"key":"key20171025112535478_ref1-bib45","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/j.1600-0447.1983.tb09716.x","article-title":"The Hospital Anxiety and Depression Scale","volume":"67","author":"Zigmond","year":"1983","journal-title":"Acta Psychiatr Scand"},{"key":"key20171025112535478_ref1-bib46","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1111\/j.1524-4733.2010.00788.x","article-title":"Methods for the collection of resource use data within clinical trials: a systematic review of studies funded by the UK Health Technology Assessment Program","volume":"13","author":"Ridyard","year":"2010","journal-title":"Value Health"},{"key":"key20171025112535478_ref1-bib47","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s40258-013-0022-4","article-title":"Resource-use measurement based on patient recall: issues and challenges for economic evaluation","volume":"11","author":"Thorn","year":"2013","journal-title":"Appl Health Econ Health Policy"},{"key":"key20171025112535478_ref1-bib48","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1002\/art.23563","article-title":"A primary care back pain screening tool: identifying patient subgroups for initial treatment","volume":"59","author":"Hill","year":"2008","journal-title":"Arthritis Rheum"},{"key":"key20171025112535478_ref1-bib49","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.pain.2005.12.012","article-title":"The importance of symptom duration in determining prognosis","volume":"121","author":"Dunn","year":"2006","journal-title":"Pain"},{"key":"key20171025112535478_ref1-bib50","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.ejpain.2005.12.008","article-title":"The Pain Self-Efficacy Questionnaire: taking pain into account","volume":"11","author":"Nicholas","year":"2007","journal-title":"Eur J Pain"},{"key":"key20171025112535478_ref1-bib51","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/0304-3959(94)00279-N","article-title":"Fear of movement\/(re)injury in chronic low back pain and its relation to behavioural performance","volume":"62","author":"Vlaeyen","year":"1995","journal-title":"Pain"},{"key":"key20171025112535478_ref1-bib52","doi-asserted-by":"crossref","DOI":"10.1201\/b11826","volume-title":"Flexible Imputation of Missing Data","author":"van Buuren","year":"2012"},{"key":"key20171025112535478_ref1-bib53","doi-asserted-by":"crossref","first-page":"c332","DOI":"10.1136\/bmj.c332","article-title":"CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials","volume":"152","author":"Schulz","year":"2010","journal-title":"BMJ"},{"volume-title":"National Schedule of Reference Costs 2013\u201314","year":"2014","author":"Department of Health","key":"key20171025112535478_ref1-bib54"},{"key":"key20171025112535478_ref1-bib55","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/hec.1693","article-title":"Missing data in trial-based cost-effectiveness analysis: the current state of play","volume":"21","author":"Noble","year":"2012","journal-title":"Health Econ"},{"volume-title":"Economic Evaluation in Clinical Trials","year":"2007","author":"Glick","key":"key20171025112535478_ref1-bib56"},{"article-title":"International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human use","volume-title":"Guideline for Good Clinical Practice E6 (R1)","year":"1996","key":"key20171025112535478_ref1-bib57"},{"volume-title":"Clinical Trials \u2013 Directive 2001\/20\/EC","author":"European Commission","key":"key20171025112535478_ref1-bib58"},{"volume-title":"Brunswick Agreements","author":"Association of Research Managers and Administrators","key":"key20171025112535478_ref1-bib59"},{"key":"key20171025112535478_ref1-bib60","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1186\/s12891-015-0787-8","article-title":"Characteristics of patients with low back and leg pain seeking treatment in primary care: baseline results from the ATLAS cohort study","volume":"16","author":"Konstantinou","year":"2015","journal-title":"BMC Musculoskelet Disord"},{"volume-title":"Stratified Care for Patients with Sciatica in Primary Care","year":"2017","author":"ISRCTN Registry","key":"key20171025112535478_ref1-bib61"}],"container-title":["Health Technology Assessment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.journalslibrary.nihr.ac.uk\/publications\/hta21600\/hta21600.xml","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/njl-admin.nihr.ac.uk\/document\/download\/2002746","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.journalslibrary.nihr.ac.uk\/publications\/hta21600\/hta21600.xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/njl-admin.nihr.ac.uk\/document\/download\/2011343","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,15]],"date-time":"2023-08-15T15:50:01Z","timestamp":1692114601000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.journalslibrary.nihr.ac.uk\/hta\/hta21600"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":61,"journal-issue":{"issue":"60","published-online":{"date-parts":[[2017,10]]}},"alternative-id":["10.3310\/hta21600"],"URL":"https:\/\/doi.org\/10.3310\/hta21600","relation":{},"ISSN":["1366-5278","2046-4924"],"issn-type":[{"type":"print","value":"1366-5278"},{"type":"electronic","value":"2046-4924"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"This content has been made freely available to all.","name":"free","label":"Free to read"}]}}